Companies Related to "ToolGen Highlights Study Results Demonstrating Utility Compatible Cas9" [Most Relevant Company Matches] RSS

05:22 EST 19th January 2019 | BioPortfolio

Here are the most relevant search results for "ToolGen Highlights Study Results Demonstrating Utility Compatible Cas9" found in our extensive corporate database of over 50,000 company records.

Showing "ToolGen Highlights Study Results Demonstrating Utility Compatible Cas9" Companies 1–25 of 1,800+


United Surgical Partners International, Inc.


CRISPR Therapeutics

CRISPR Therapeutics is a biopharmaceutical company created to translate CRISPR-Cas9, a breakthrough gene-editing technology, into transformative medicines for serious human genetic diseases. Its vision is to cure serious human diseases at the molecular level using CRISPR-Cas9. CRISPR Therapeutics is a Swiss company with operations in London, UK. ...

Intellia Therapeutics

Intellia Therapeutics was formed in 2014 to lead the industry in one of the most promising new areas of therapeutic development: gene editing and repair using CRISPR-Cas9 technology. Intellia holds exclusive access to one of the most comprehensive intellectual property platforms available for the therapeutic use of CRISPR-Cas9. The company is advancing a b...

Compatible Technology International


Health outcomes aren't jeopardized when patients participate in randomized clinical trials of approved treatments, according to a new study. The results address misgivings some physicians have had about whether enrolling patients in a clinical trial might have a detrimental impact on their ability to receive individualized treatment. Conducted by a team led by Yale University's Dr. Cary P. Gross, ...

Ingersoll Rand

In the About Us section, you can find in-depth information about Ingersoll Rand. Beginning with our Company Overview, featuring information on our five global growth sectors, revenue highlights and a comprehensive listing of each sector's businesses and brands.Journey into Ingersoll Rand history and learn about our rich heritage through our History timeline, showcasing innovations, acquisitions a...

Intellia Therapeutics, Inc.

Intellia Therapeutics is a leading gene-editing company focused on the development of proprietary products utilizing the recently discovered CRISPR/Cas9 technology. Intellia intends to advance its pipeline and potentially develop a new drug class by leveraging its leading scientific and clinical development expertise and its exclusive access to one of the ...

The site is a central, widely accessible, web-based repository for clinical study results in a reader-friendly, standardized format. This database will serve the valuable function of making clinical trial results for for many marketed pharmaceuticals more transparent. More importantly, it is designed as a key tool to provide information to practicing physicians and their p...

Del Global Technologies Corp.


UTILITY therapeutics Limited

UTILITY therapeutics is focused on developing and commercialising antibiotics in the US, to address the significant threat faced by healthcare systems and patients from multi-drug resistant bacterial infections. The World Health Organisation has stated that antibiotic resistance is one of the biggest threats to global health, food security, and development...

UTILITY therapeutics Ltd

UTILITY is focused on developing and commercialising antibiotics in the US, to address the significant threat faced by healthcare systems and patients from multi-drug resistant bacterial infections. The World Health Organisation has stated that antibiotic resistance is one of the biggest threats to global health, food security, and development today.

Computer Programs and Systems, Inc.

CPSI is a leading provider of healthcare information solutions for community hospitals with over 650 client hospitals in 47 states and the District of Columbia. Founded in 1979, the Company is a single-source vendor providing comprehensive software and hardware products, complemented by complete installation services and extensive support. Its fully integr...

bitop Aktiengesellschaft für biotechnische Optimierung

bitop was founded in 1993 by researchers from the private Witten/Herdecke University.The main area of expertise of bitop is the use of microorganisms for the production of high-grade products. bitop is the world-leading company in the development and production of new compatible solutes=extremolytes from extremophilic microorganisms. Compatible solutes are stabilizers of biological structures ( pr...

Alexion Pharmaceuticals, Inc.

Fourth Quarter 2011 Financial Highlights:

Corcept Therapeutics

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the development of drugs for the treatment of severe psychiatric and neurological diseases. Our lead product, CORLUX, is currently in three Phase 3 clinical trials for the treatment of the psychotic features of psychotic major depression (PMD), a disorder that affects approximately three million adults in the United States ea...

The National Stroke Research Institute

The National Stroke Research Institute is directed by Professor Geoffrey Donnan. The NSRI has played a key role in national and international trials of treatment for stroke which have greatly improved services. In addition, the Institute has completed the initial phase of the North East Melbourne Stroke Incidence Study (NEMESIS) in Melbourne. The results from the study will teach us a lot about th...

MedQuist Holdings Inc.

Fourth Quarter Highlights

Numoda Corporation

Numoda is the first full-service clinical research organization (CRO) to design, implement and consolidate clinical trial data and information in real time. Numoda delivers early results and efficiency, from protocol development through final study report, while providing sponsors with visibility into each study, that is simply not possible elsewhere. Numoda was founded in 1996, by an experienced ...

CEL-SCI Corporation CEL-SCI Corporation

CEL-SCI's work is focused on finding the best way to activate the immune system to fight cancer and infectious diseases. Its lead investigational immunotherapy, Multikine* (Leukocyte Interleukin, Injection), is currently being studied in a pivotal Phase 3 clinical trial as a potential neoadjuvant treatment for patients with squamous cell carcinoma of the h...

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

Algemene Communicatie en Netwerk Integratie

A.C.N.I. provides solutions for Internet Integration projects. From study, advise to integration, sourcing and coordination. A.C.N.I. helps your company to get results form using the high speed Internet.

MedAvante, Inc.

MedAvante is the premier global provider of centralized expert psychiatric rating and monitoring services to the pharmaceutical, biotechnology and medical device industries. Our flagship service, Remote Centralized Ratings are real-time assessments, either by telephone or videoconference, of subjects in global drug trials. Centralizing the assessors and blinding them to study protocols, results in...

bluebird bio, Inc. bluebird bio to Present Updated Clinical Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti- BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASCO Annual Meeting

“The Global Learning Series”

For more information about “Molecular Imaging Highlights,” please visit our blog, Global and Main Street and our Twitter page:

Artesian Resources Corporation

Artesian Resources Corporation operates as the holding company of eight wholly-owned subsidiaries offering water, wastewater and other services on the Delmarva Peninsula. Artesian Water Company, the principal subsidiary, is the oldest and largest investor-owned public water utility on the Delmarva Peninsula and has been providing water service since 1905. ...

More From BioPortfolio on "ToolGen Highlights Study Results Demonstrating Utility Compatible Cas9"

Quick Search


Corporate Database Quicklinks